Search Results - "Tropè, Claes G"

Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin by Park, Joon Tae, Chen, Xu, Tropè, Claes G, Davidson, Ben, Shih, Ie-Ming, Wang, Tian-Li

“…Amplification of the Notch3 locus has been detected in ovarian high-grade serous carcinoma (HGSC), the most common and malignant type of ovarian cancer. We…”
Get full text

Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion by Davidson, Ben, MD, PhD, Smith, Yoav, PhD, Nesland, Jahn M., MD, PhD, Kærn, Janne, MD, PhD, Reich, Reuven, PhD, Tropè, Claes G., MD, PhD

“…Summary Advanced-stage ovarian carcinoma is a highly lethal malignancy, yet no widely accepted prognostic panels exist to date in this disease. The objective…”
Get full text

The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas by Wang, Zhihui, Tropè, Claes G, Suo, Zhenhe, Trøen, Gunhild, Yang, Guanrui, Nesland, Jahn M, Holm, Ruth

“…14-3-3 sigma promotes G2/M cell cycle arrest by sequestering cyclin B1-CDC2 complex in cytoplasm. Down-regulation of 14-3-3sigma, which has been demonstrated…”
Get full text

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer by Vergote, Ignace, Tropé, Claes G, Amant, Frédéric, Kristensen, Gunnar B, Ehlen, Tom, Johnson, Nick, Verheijen, René H.M, van der Burg, Maria E.L, Lacave, Angel J, Panici, Pierluigi Benedetti, Kenter, Gemma G, Casado, Antonio, Mendiola, Cesar, Coens, Corneel, Verleye, Leen, Stuart, Gavin C.E, Pecorelli, Sergio, Reed, Nick S

“…In this randomized trial, standard primary debulking surgery followed by chemotherapy was compared with neoadjuvant chemotherapy followed by debulking surgery…”
Get full text

The clinical and diagnostic role of microRNAs in ovarian carcinoma by Davidson, Ben, Tropé, Claes G, Reich, Reuven

“…Abstract Objective MicroRNAs (miRNAs, miRs) are non-coding RNAs which post-transcriptionally regulate mRNA synthesis. Data regarding the expression and…”
Get full text

Diagnosis and treatment of sarcoma of the uterus. A review by Tropé, Claes G, Abeler, Vera M, Kristensen, Gunnar B

“…The histopathological classification and staging system for uterine sarcoma (US) were revised in 2003 and 2009, respectively. However, there is currently no…”
Get more information

Long-Term Outcomes After Pelvic Radiation for Early-Stage Endometrial Cancer by ONSRUD, Mathias, CVANCAROVA, Milada, HELLEBUST, Taran P, TROPE, Claes G, KRISTENSEN, Gunnar B, LINDEMANN, Kristina

“…This follow-up of a randomized study was conducted to assess the long-term effects of external beam radiation therapy (EBRT) in the adjuvant treatment of…”
Get full text

Advanced Ovarian Cancer: Primary or Interval Debulking? Five Categories of Patients in View of the Results of Randomized Trials and Tumor Biology: Primary Debulking Surgery and Interval Debulking Surgery for Advanced Ovarian Cancer by Makar, Amin P., Tropé, Claes G., Tummers, Philippe, Denys, Hannelore, Vandecasteele, Katrien

“…Background. Standard treatment of stage III and IV advanced ovarian cancer (AOC) consists of primary debulking surgery (PDS) followed by chemotherapy. Since…”
Get full text

Ovarian cancer: diagnostic, biological and prognostic aspects by Davidson, Ben, Tropé, Claes G

“…Ovarian cancer remains the most lethal gynecologic malignancy, owing to late detection, intrinsic and acquired chemoresistance and remarkable heterogeneity…”
Get full text

MicroRNAs in Ovarian Cancer by Katz, Betina, MD, PhD, Tropé, Claes G., MD, PhD, Reich, Reuven, PhD, Davidson, Ben, MD, PhD

“…Summary Ovarian cancer, consisting predominantly of ovarian carcinoma, is the eighth most common cancer in women and the most lethal gynecologic malignancy…”
Get full text

Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions by Slipicevic, Ana, Holth, Arild, Hellesylt, Ellen, Tropé, Claes G, Davidson, Ben, Flørenes, Vivi Ann

“…Abstract Objective Wee1-like kinase (Wee1) is a tyrosine kinase which negatively regulates entry into mitosis at the G2 to M-phase transition and has a role in…”
Get full text

Epithelial-mesenchymal transition in ovarian carcinoma by Davidson, Ben, Tropé, Claes G, Reich, Reuven

“…Ovarian cancer is the most lethal gynecologic malignancy, with the majority of patients dying within 5 years of diagnosis. This poor survival of patients…”
Get full text

Ezrin Is Associated with Disease Progression in Ovarian Carcinoma by Horwitz, Vered, Davidson, Ben, Stern, Dganit, Tropé, Claes G, Tavor Re'em, Tali, Reich, Reuven

“…Ezrin and p130Cas are structural proteins with an important role in signaling pathways and have been shown to promote cancer dissemination. We previously…”
Get full text

Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma by Vaksman, Olga, MSc, Hetland, Thea Eline, MD, Trope', Claes G., MD, PhD, Reich, Reuven, PhD, Davidson, Ben, MD, PhD

“…Summary MicroRNAs are posttranscriptional regulators of messenger RNA synthesis that are intracellularly processed and transferred by the microRNA-regulating…”
Get full text

Expression and clinical role of long non-coding RNA in high-grade serous carcinoma by Filippov-Levy, Natalie, Cohen-Schussheim, Hallel, Tropé, Claes G., Hetland Falkenthal, Thea E., Smith, Yoav, Davidson, Ben, Reich, Reuven

“…To profile long non-coding RNA (lncRNA) expression at the various anatomic sites of high-grades serous carcinoma (HGSC) and in effusion-derived exosomes…”
Get full text

TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma by Broner, Esther Channah, MSc, Tropé, Claes G., MD, PhD, Reich, Reuven, PhD, Davidson, Ben, MD, PhD

“…The objective of this study was to analyze the expression and clinical role of molecules involved in exosome synthesis and secretion in high-grade serous…”
Get full text

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection by Tian, Wen-Juan, Chi, Dennis S., Sehouli, Jalid, Tropé, Claes G., Jiang, Rong, Ayhan, Ali, Cormio, Gennaro, Xing, Yan, Breitbach, Georg-Peter, Braicu, Elena Ioana, Rabbitt, Catherine A., Oksefjell, Halldis, Fotopoulou, Christina, Meerpohl, Hans-Gerd, du Bois, Andreas, Berek, Jonathan S., Zang, Rong-Yu, Harter, Philipp

“…Background To develop a risk model for predicting complete secondary cytoreductive surgery (SCR) in patients with recurrent ovarian cancer. Methods Individual…”
Get full text

The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas by Agostini, Antonio, Brunetti, Marta, Davidson, Ben, Tropé, Claes G., Eriksson, Ane Gerda Z., Heim, Sverre, Panagopoulos, Ioannis, Micci, Francesca

“…Different microRNAs are dysregulated in ovarian cancer where some of them have proved to be valid biomarkers. miRNA profiling analyses have shown that the…”
Get full text

Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma by Harel-Dassa, Keren, Yedgar, Saul, Tropé, Claes G., Davidson, Ben, Reich, Reuven

“…The objective of this study was to analyze the expression and clinical role of phospholipase D (PLD) in high-grade serous carcinoma (HGSC). PLD1 and PLD2…”
Get full text

Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV? by Tropé, Claes G, Elstrand, Mari B, Sandstad, Berit, Davidson, Ben, Oksefjell, Halldis

“…Abstract Objectives The aim of this study was to investigate the impact of surgical approach, the extent of surgery and chemotherapy on overall survival in…”
Get full text